Skip to main content
. 2019 Jul 30;20:169. doi: 10.1186/s12931-019-1134-7

Fig. 6.

Fig. 6

Change from baseline in ACQ-5 score (a) and proportion of responders achieving a ≥ 0.5-point change from baseline in ACQ-5 score (b). Mepolizumab 100 mg SC versus placebo. ACQ-5 Asthma Control Questionnaire, BMI body mass index, CI confidence interval, SC subcutaneous